Acute bacterial skin and skin structure infections: current perspective
Indian Journal of Dermatology, 2011 A skin and skin structure infection is a bacterial infection of skin and associated tissues. It may be complicated skin and skin structure infection or uncomplicated skin and skin structure infection. Recently, the Food and Drug Administration has called
Megha Shah, Hetal D Shah
doaj +4 more sources
Review of oritavancin for the treatment of acute bacterial skin and skin structure infections [PDF]
Farmacia Hospitalaria, 2018 Objective: To assess critically oritavancin, a second-generation lipoglycopeptide, for the treatment of Acute Bacterial Skin and Skin Structure Infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus ...
Ana Alejandra García Robles +4 more
doaj +9 more sources
Diabetes and acute bacterial skin and skin structure infections [PDF]
Diabetes Research and Clinical Practice, 2021 Acute bacterial skin and skin structures infections (ABSSSIs) are associated with high morbidity, costs and mortality in patients with diabetes mellitus. Their appropriate management should include several figures and a well-organized approach. This review aims to highlight the interplay between diabetes and ABSSSIs and bring out the unmet clinical ...
Stefano Del Prato +2 more
exaly +7 more sources
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections [PDF]
New England Journal of Medicine, 2019 Acute bacterial skin and skin-structure infections are associated with substantial morbidity and health care costs. Omadacycline, an aminomethylcycline antibiotic that can be administered once daily either orally or intravenously, is active against pathogens that commonly cause such infections, including antibiotic-resistant strains.In this double ...
Lynne Garrity-Ryan +2 more
exaly +10 more sources
Necessity of vancomycin trough concentrations to manage uncomplicated acute bacterial skin and skin structure infections: a laboratory stewardship analysis [PDF]
Drugs in Context, 2023 Background: Recent recommendations by the American Society of Health System Pharmacists and Infectious Disease Society of America have provided guidance regarding vancomycin dosing and monitoring in serious infections (including methicillin-resistant ...
Andrew Merker +3 more
doaj +2 more sources
Long-Acting Antibiotics: New Opportunities Beyond Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)! [PDF]
AntibioticsCurrently, two long-acting antibiotics are available: oritavancin (ORI) and dalbavancin (DBV) [...]
Emanuele Pontali +3 more
doaj +2 more sources
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections. [PDF]
Drugs, 2020 The global spread of antibacterial-resistant strains, especially methicillin-resistant Staphylococcus aureus (MRSA) for acute bacterial skin and skin structure infections (ABSSSIs), has driven the need for novel antibacterials. Delafloxacin [Quofenix™ (EU); Baxdela® (USA)], a new fluoroquinolone (FQ), has a unique chemical structure that enhances its ...
Scott LJ.
europepmc +4 more sources
The future approach for the management of acute bacterial skin and skin structure infections. [PDF]
Curr Opin Infect DisPurpose of review To discuss the new available options for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and how to implement in the clinical practice innovative approaches for their management.
Tiseo G, Falcone M.
europepmc +3 more sources
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients [PDF]
Infectious Diseases and Therapy, 2020 Introduction Acute bacterial skin and skin structure infections (ABSSSI) are an increasing cause of admission in the self-pay population. We previously reported that patients with ABSSSI discharged to receive dalbavancin showed a decreased length of stay
Adam G. Pizzuti +5 more
doaj +2 more sources
Omadacycline for the treatment of acute bacterial skin and skin structure infections: a systematic review and network meta-analysis [PDF]
BMC Infectious DiseasesBackground Few studies have compared the efficacy and safety of omadacycline with other treatments for acute bacterial skin and skin structure infections (ABSSSI). Therefore, updated meta-analyses on this topic is necessary.
Wen-qiang Kong +5 more
doaj +2 more sources